Pfizer’s Adcetris combination regimen gets US FDA approval to …
1 day ago · Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Adcetris (brentuximab vedotin) in combination with lenalidomide and a rituximab product for the treatment of adult patients with relapsed or refractory large B ...
Tivic Health acquires exclusive global rights to TLR5 agonist …
1 day ago · Tivic Health Systems, Inc, a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health, announced it has acquired worldwide exclusive license rights from Statera Biopharma to the late-stage Toll-like Receptor 5 (TLR5 ...
News - Pharmabiz.com
Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
Roche’s Evrysdi tablet receives US FDA approval for the treatment …
1 day ago · Roche, announced that the US Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an Evrysdi (risdiplam) tablet for people living with spinal muscular atrophy (SMA). Evrysdi is the only non-invasive disease-modifying treatment for SMA. The 5 mg Evrysdi tablet can either ...
Lilly's Omvoh receives US FDA approval to treat Crohn's disease in …
Jan 17, 2025 · Lilly's Omvoh receives US FDA approval to treat Crohn's disease in adults: Indianapolis Friday, January 17, 2025, 12:00 Hrs [IST] Eli Lilly and Company announced that the US Food and Drug Administration (FDA) has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's disease in adults.
US FDA approves AbbVie’s interleukin-23 inhibitor, Skyrizi to treat ...
Jun 21, 2022 · US FDA approves AbbVie’s interleukin-23 inhibitor, Skyrizi to treat moderately to severely active Crohn's disease: North Chicago, Illinois Tuesday, June 21, 2022, 14:00 Hrs [IST]
Daiichi Sankyo & AstraZeneca’s Datroway gets US FDA approval …
Jan 20, 2025 · Daiichi Sankyo & AstraZeneca’s Datroway gets US FDA approval for patients with previously treated metastatic HR positive, HER2 negative breast cancer
Phillips Medisize expands its inhalation drug delivery capabilities
Jan 9, 2025 · Phillips Medisize expands its inhalation drug delivery capabilities: Hudson, Wisconsin Thursday, January 9, 2025, 11:00 Hrs [IST] Molex, a parent to Phillips Medisize announced that it has completed, through an affiliate, the previously announced acquisition of Vectura Group Ltd. (Vectura) from Vectura Fertin Pharma Inc., a subsidiary of Philip Morris International Inc.
Lupin receives US FDA tentative approval for generic Symtuza tablets
Feb 3, 2025 · Lupin receives US FDA tentative approval for generic Symtuza tablets: Our Bureau, Mumbai Monday, February 3, 2025, 13:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for darunavir, cobicistat, emtricitabine, and tenofovir alafenamide ...
Pfizer’s Hympavzi receives US FDA approval to treat adults and ...
Oct 14, 2024 · Pfizer’s Hympavzi receives US FDA approval to treat adults and adolescents with haemophilia A or B without inhibitors: New York Monday, October 14, 2024, 18:00 Hrs [IST]